Coexisting Alterations of MHC Class I Antigen Presentation and IFNγ Signaling Mediate Acquired Resistance of Melanoma to Post–PD-1 Immunotherapy

RRIDs were included in the Cancer Immunology Research paper "Co-existing alterations of MHC class I antigen pre…" (https://t.co/LF4y6F1yhh). Thank you for making your #methodsmatter. #RRID

RT @DoniaMarco: **Acquired resistance to #melanoma Immunotherapy** Approx. 30% of patients with #melanoma who initially respond to #Immuno…

RT @DoniaMarco: **Acquired resistance to #melanoma Immunotherapy** Approx. 30% of patients with #melanoma who initially respond to #Immuno…

RT @DoniaMarco: **Acquired resistance to #melanoma Immunotherapy** Approx. 30% of patients with #melanoma who initially respond to #Immuno…